## 



## 

## 

## 




## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 

## 



## 

## 



## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 



## 

## 

## 

## 



## 

## 

## 

## 



## 

## 

## 

## 

## 



|ID<br>Ih<br>tl<br>ID<br>CL<br>e<br>io|0 <br>fl<br>r <br>0. <br>n <br>Ql<br>ID<br>0|-I<br> 0<br>Ql<br> r<br> o.<br> 0<br>0<br>OQ<br>-h0<br>Xl<br>IDn0<br>Ol<br>0<br>0<br>r<br>0.|2<br>ID<br>C<br>Ql3<br>r<br>0.|2<br>ID<br>ttl<br>ID<br>tl<br>~ 3<br>ID<br>e<br>ID<br>ID0r<br>CLÃ<br>0. r|2<br>ID<br>ttl<br>ID<br>tl<br>~ 3<br>ID<br>e<br>ID<br>ID0r<br>CLÃ<br>0. r|-t <br>0<br>ex <br>o. <br>r<br>I7l|n<br>QI<br> 0<br>ID<br>Ql<br> n<br>fD|ITIx'0e<br>CL<br>I7l0|tD<br>R&~<br>ID<br>3<br>ID<br>Qln(<br>ID|tD<br>R&~<br>ID<br>3<br>ID<br>Qln(<br>ID|tD<br>R&~<br>ID<br>3<br>ID<br>Qln(<br>ID|0<br>I<br>n<br>CLo<br>QI<br>o' ~<br>' ID<br>0'<br>000'I<br>tu<br>0|0<br>I<br>n<br>CLo<br>QI<br>o' ~<br>' ID<br>0'<br>000'I<br>tu<br>0|00<br>0<br>CO<br>r0<br>0|00<br>0<br>CO<br>r0<br>0|CI03<br>ID<br>0||||Ol<br>m<br>I o<br>I<br>& O<br>0<br>ll 0<br>5<br>Cl|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|0|Ql<br>CL|Ol|||ID|||||||0, OQ|||||||||
|x'0<br>ID<br>CL||||||||||||00<br>7II<br>ID||||||||QO(|
|ID||||||||||||CI.<br>ID||||||||6|
|||||||||||||00|||||||||
|||||||||||||9.|||||||||
|||||||||||||ID|||||||||
|||||||||||||||||||20||5'I|
|||||||||||||||||||||'CI|
|||||||||||||||||||ID||Q<br>CI|
||||||||Ol<br>Ctt<br>V<br>00<br>Ca<br>SRO||00<br>0|0||Oa<br> 0 0<br>Vt||0<br>Ca<br>Vl||Ul|r0<br>ID0.|||Q.<br>O.|
|||||||||||||||||||||COD|
||0<br>~O|N<br>I/I<br>Ul<br>0 0||ID<br>ID|Ul<br>Do||N<br>I<br>Ca<br>th<br>CO<br>VJ<br>g<br>W|IA<br>UI<br>GO<br>tD|||||||||e<br>r<br>0. 3<br>ttt<br>IO|||Ql<br>n|
|||00<br>ID<br>O<br>CU<br>V<br>N||00<br>Ul|0|'4<br>00<br>Vl|W<br>Ut<br>O<br>Ctt|Ul<br>VJ|N|||t4<br>i<br>Dt<br>ID<br>V<br>GI<br>I|tot<br>I<br>Go<br>UJ||W<br>VJ<br>J<br>IA<br>VI<br>\D<br>Ul<br>CO<br>EU||ttt|N<br>ClNO<br>N e|||
||||||||||||||||||||gl<br>ID||
|||Ul<br>00 0<br>ID||0<br>N<br>I|UJ<br>Ca<br>O|Cll<br>IJJ<br> 8|W<br>Vl<br>V<br>00<br>GO<br>V V<br>ol||W<br>COO|||0<br>Vl<br>W<br>ID<br>Co|0||Co<br>I<br>GO<br>I|||to|n'<br>ID<br>CL||
||Ctt<br>Ul<br>io|Ul<br>ID<br>IJI<br>IA<br>O<br>Ul<br>Ol<br>CttN||vl<br>O|ao<br>Go|0<br>IU|N<br>ID<br>N<br>$8 Ã|||tool<br>IA<br>ID<br>W|00<br>N<br>I<br>GO<br>W<br>ID<br>R V, CW|||||Vl<br>tD<br>N|m|r<br>IO|Cle<br>IDt<br>Ql||
|||N<br>to<br>Jh<br>OI<br>ID||Ulrl<br>0|||IU<br>N|N0<br>CB<br>ca<br>w||NN||00 V<br>Vl<br>W<br>Ol||||Vt<br>Ul<br>W<br>ID<br>GOD<br>I||N<br>Cl<br>ID <br>N <br>O|o<br> g||
|||N|||||||||||||||||||





## 

## 




## 

## 

||ZOZO/Z1|2019/20|
|---|---|---|
||f|f|
|Net income/(expenditure)<br>as per the statement<br>of financial activities|111,875|-50,709|
|Adjustments<br>for|1,146|2,583|
|Depreciation<br>charges|-48|-144|
|Interest from investments<br>(Increase)/decrease<br>in debtors<br>increase/(decrease)<br>in creditors<br>Net cash generated<br>/(used)<br>in operating activities|29,799<br>6,973<br>90,149|17,096<br>-11,045<br>-42,219|
|Cash flows from investing<br>activities|48|144|
|Interest frominvestments|0|0|
|Purchase ofequipment<br>Net cash provided<br>by/(used<br>in) investing<br>activities|48|144|
|Net increase/(decrease)<br>in cash and cash equivalents<br>Cash and cash equivalents<br>atthe beginning<br>ofthe year<br>Cash and cash equivalents<br>at the end ofthe year|90,196<br>217,696<br>307,892|-42,075<br>259,771<br>217,696|





## 



## 

## 

## 

## 

## 



## 

## 

|3|Analysis ofincome and expenditure|Analysis ofincome and expenditure|by charitable|by charitable|activity|activity||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|||||||2021||||2020||||||
||||||Income||Expenditure|||Income|Expenditure|||||
|||||||6||6||6||6||||
||Awareness<br>and best practice<br>Support and information<br>Research|||||0<br>81,420<br>0||-60,121<br>-173,997<br>-6,451||0<br>29,113<br>2,285||97,442<br>67,003<br>18,785||||
|||||||81,420||-240,569||31,398||183,230||||
||Income is analysed<br>accordmg to|restrictions||imposed||by donors||and funde|ra.|||||||
|4|Net inmming<br>resources|||||||||||||||
|||||||||||2021||2,020||||
|||||||||||6||1||||
||Net incoming resources are ytated after chargmg|||||||||||||||
||Operating<br>lease - land and buildings<br>Independent<br>examiner's fees|||||||||21,976<br>1,500||22,043<br>1,500||||
|5|Totalresources<br>expended||||||Support<br>Awareness<br>&||||Information||Research|Fundraising|Total|
|||||||||costs|best|practice|&|support||||
|||||||||6||6||6||||
||Yearto March 2021|||||||||||||||
||Employment<br>and training<br>premises and general overheads<br>Pnnting<br>and communications<br>Independent<br>examination<br>and accountancy<br>Conferences,<br>meetings<br>and travel<br>Direct project costs<br>Fundraising<br>and prize draw expenses<br>Grants awarded/(re<br>cove redj<br>Apportioned<br>support costs<br>Total|||||||28269<br>39355<br>0<br>1867<br>241<br>0<br>0<br>0<br>69732<br>0||40954<br>0<br>4895<br>0<br>0<br>753<br>D<br>0<br>13519<br>60121||61031<br>0<br>2664<br>0<br>0<br>71176<br>0<br>0<br>39I.27<br>173997|0<br>5000<br>1451<br>6451|35940<br>0<br>0<br>0<br>0<br>0<br>17956<br>0<br>15635<br>69531|166194<br>39355<br>7559<br>1867<br>241<br>71929<br>17956<br>5000<br>0<br>310100|
||Yearto March 2020<br>Employment<br>and training<br>Premises and general overheads<br>Pnnting<br>and communications<br>Independent<br>examination<br>and accountancy<br>Conferences,<br>meetings<br>and travel<br>Direct project costs<br>Fundraising<br>and prize draw eripenses<br>Grants awarded/(recoveredl<br>Apportioned<br>support mats<br>Total|||||||24825<br>44657<br>0<br>2900<br>5944<br>0<br>0<br>0<br>-78325<br>0||6<br>50419<br>0<br>17024<br>0<br>0<br>1985<br>0<br>0<br>28014<br>97,442||34669<br>0<br>2664<br>0<br>0<br>10408<br>0<br>0<br>19263<br>67,003|6<br>0<br>0<br>0<br>0<br>0<br>0<br>0<br>13384<br>5400<br>18,785|6<br>39050<br>0<br>0<br>0<br>0<br>0<br>24517<br>0<br>25649<br>89,216|6<br>148963<br>44657<br>19688<br>2900<br>5944<br>12392<br>24517<br>13384<br>0<br>272,446|
|||||||||||2021||2020||||
|||||||||||||6||||
||Support costs include<br>governance|costs|of|||||||1,800||7,188||||
||Grants awarded<br>included|||||||||||||||
||To individuals|||||||||0||0||||
||To organisations|||||||||5,000||13,385||||





## 

## 

## 

## 

|6|Staff costs|2020/21|2019/20|
|---|---|---|---|
|||f.|f|
||Salaries and wages<br>Social security costs<br>Pension contributions|140,424<br>9,833<br>7370<br>157,627|122,619<br>9,250<br>5,589<br>137,458|
||Staff employed<br>under service contracts<br>Other employment<br>and training costs<br>Total employment<br>and training costs|0<br>59<br>157,686|0<br>784<br>138,242|



## 

|8|Non-current<br>assets|||
|---|---|---|---|
||Office equipment<br>and fixtures||6|
||||22317|
||Cost at 1April 2020||0|
||Additions||22317|
||Cost at31March 2021|||
||||21171|
||Depreciation<br>at1April 2020|||
||Chargefor the year<br>Depreciation<br>at 31March|2020|21171|
||Net book value at 1April 2020<br>Net book value at31March 2021||1146<br>1146|
||Investment<br>in subsidiary|||
||Investment<br>in Dystonia|UK Ltd||





## 

## 

## 

## 



## 



## 

## 

## 

|15|Activity onrestricted|Activity onrestricted|funds|Opening|Income|Transfers|Expenditure|Closing<br>balance|
|---|---|---|---|---|---|---|---|---|
|||||balance|||||
|||||6|6|E|E|E|
||Awareness<br>Information<br>Research|and best practice<br>and support||3,000<br>25,770<br>15,100<br>43,870|0<br>81,420<br>0<br>81420|0<br>-684<br>0|0<br>-67,866<br>0<br>-67,866|3,000<br>38,640<br>15,100<br>56,740|



## 

